NOLC1 and hepatocellular carcinoma: NOLC1, PAICS, and TEX10 expression are associated with cancer stemness, poor prognosis, and resistance to interventional chemo/radiotherapy in patients with breast cancer, esophageal cancer, hepatocellular carcinoma or melanoma (25, 37–41).